SEARCH

SEARCH BY CITATION

References

  • 1
    Nagler, A., Lanier, L. L., Cwirla, S. and Phillips, J. H., Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989. 143: 31833191.
  • 2
    Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633640.
  • 3
    Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E. and Caligiuri, M. A., Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001. 97: 31463151.
  • 4
    Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Orange, J. S., Schatz, F., Masch, R. et al., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003. 198: 12011212.
  • 5
    Hanna, J., Bechtel, P., Zhai, Y., Youssef, F., McLachlan, K. and Mandelboim, O., Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 2004. 173: 65476563.
  • 6
    Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M. and Caligiuri, M. A., CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003. 101: 30523057.
  • 7
    Ferlazzo, G., Thomas, D., Lin, S. L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A. and Munz, C., The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004. 172: 14551462.
  • 8
    Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K. and Doherty, J. M. et al., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009. 457: 722725.
  • 9
    Vivier, E., Spits, H. and Cupedo, T., Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat. Rev. Immunol. 2009. 9: 229234.
  • 10
    Moffett-King, A., Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002. 2: 656663.
  • 11
    Li, M. O. and Flavell, R. A., TGF-beta: a master of all T cell trades. Cell 2008. 134: 392404.
  • 12
    Fortunel, N. O., Hatzfeld, A. and Hatzfeld, J. A., Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000. 96: 20222036.
  • 13
    Bellone, G., Aste-Amezaga, M., Trinchieri, G. and Rodeck, U., Regulation of NK cell functions by TGF-beta 1. J. Immunol. 1995. 155: 10661073.
  • 14
    Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R. et al., Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 2003. 100: 41204125.
  • 15
    Eriksson, M., Meadows, S. K., Wira, C. R. and Sentman, C. L., Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J. Leukoc. Biol. 2004. 76: 667675.
  • 16
    Trotta, R., Col, J. D., Yu, J., Ciarlariello, D., Thomas, B., Zhang, X., Allard, J. et al., TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. J. Immunol. 2008. 181: 37843792.
  • 17
    Laouar, Y., Sutterwala, F. S., Gorelik, L. and Flavell, R. A., Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 2005. 6: 600607.
  • 18
    Blom, B. and Spits, H., Development of human lymphoid cells. Annu. Rev. Immunol. 2006. 24: 287320.
  • 19
    Chan, A., Hong, D. L., Atzberger, A., Kollnberger, S., Filer, A. D., Buckley, C. D., McMichael, A. et al., CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J. Immunol. 2007. 179: 8994.
  • 20
    Romagnani, C., Juelke, K., Falco, M., Morandi, B., D'Agostino, A., Costa, R., Ratto, G. et al., CD56brightCD16- killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007. 178: 49474955.
  • 21
    Takahashi, E., Kuranaga, N., Satoh, K., Habu, Y., Shinomiya, N., Asano, T., Seki, S. and Hayakawa, M., Induction of CD16+CD56bright NK cells with antitumour cytotoxicity not only from CD16-CD56bright NK Cells but also from CD16-CD56dim NK cells. Scand. J. Immunol. 2007. 65: 126138.
  • 22
    Huntington, N. D., Legrand, N., Alves, N. L., Jaron, B., Weijer, K., Plet, A., Corcuff, E. et al., IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 2009. 206: 2534.
  • 23
    Keskin, D. B., Allan, D. S., Rybalov, B., Andzelm, M. M., Stern, J. N., Kopcow, H. D., Koopman, L. A. and Strominger, J. L., TGFbeta promotes conversion of CD16+peripheral blood NK cells into CD16-NK cells with similarities to decidual NK cells. Proc. Natl. Acad. Sci. USA 2007. 104: 33783383.
  • 24
    Vosshenrich, C. A., Garcia-Ojeda, M. E., Samson-Villeger, S. I., Pasqualetto, V., Enault, L., Richard-Le Goff, O., Corcuff, E. et al., A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 2006. 7: 12171224.
  • 25
    Silva, A., Andrews, D. M., Brooks, A. G., Smyth, M. J. and Hayakawa, Y., Application of CD27 as a marker for distinguishing human NK cell subsets. Int. Immunol. 2008. 20: 625630.
  • 26
    Poli, A., Michel, T., Theresine, M., Andres, E., Hentges, F. and Zimmer, J., CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009. 126: 458465.
  • 27
    Hayakawa, Y., Huntington, N. D., Nutt, S. L. and Smyth, M. J., Functional subsets of mouse natural killer cells. Immunol. Rev. 2006. 214: 4755.
  • 28
    Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E. and Walzer, T., Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009. 113: 54885496.
  • 29
    Gregoire, C., Chasson, L., Luci, C., Tomasello, E., Geissmann, F., Vivier, E. and Walzer, T., The trafficking of natural killer cells. Immunol. Rev. 2007. 220: 169182.
  • 30
    Yu, J., Mao, H. C., Wei, M., Hughes, T., Zhang, J., Park, I. K., Liu, S. et al., CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 2010. 115: 274281.
  • 31
    Dulphy, N., Haas, P., Busson, M., Belhadj, S., Peffault de Latour, R., Robin, M., Carmagnat, M. et al., An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J. Immunol. 2008. 181: 22272237.
  • 32
    La Motte-Mohs, R. N., Herer, E. and Zuniga-Pflucker, J. C., Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 2005. 105: 14311439.